Showing results (81-90 of 178) with videos related to

Sort By:
Pageof 18
Cancer Research|May 1, 1984
Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentrationL J Murphy, L C Murphy, E Vrhovsek, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1986
Modulation of lactogenic receptors by progestins in cultured human breast cancer cellsL J Murphy, L C Murphy, B Stead, et al.
The Journal of Biological Chemistry|July 25, 1990
Progesterone receptor regulation by retinoic acid in the human breast cancer cell line T-47DC L Clarke, S D Roman, J Graham, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 1, 1997
Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cellsA deFazio, Y E Chiew, M McEvoy, et al.
Molecular and Cellular Biology|November 14, 2000
Regulation of the functional interaction between cyclin D1 and the estrogen receptorJ Lamb, M H Ladha, C McMahon, et al.
Oncogene|June 30, 2007
Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiationC E Caldon, C S L Lee, R L Sutherland, et al.
The Journal of Biological Chemistry|September 5, 1992
Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell linesA deFazio, Y E Chiew, C Donoghue, et al.
Cancer Research|February 1, 1986
Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cellsL J Murphy, R L Sutherland, B Stead, et al.
Cancer Research|August 1, 1988
Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cellsR R Reddel, I E Alexander, M Koga, et al.
Molecular Endocrinology (Baltimore, Md.)|January 1, 1997
Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21E A Musgrove, C S Lee, A L Cornish, et al.
Pageof 18